Skip to content

Comparison Study of efficacy of skin pigment cell graft and topical calcipotriol cream with skin pigment cell graft in Treatment of Vitiligo

Comparison Study of efficacy of basal cell layer suspension and topical calcipotriol with basal layer suspension in Treatment of Stable Vitiligo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014071418373N1
Enrollment
20
Registered
2014-08-04
Start date
2014-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. Vitiligo

Interventions

Intervention 1: In the first group : Epidermal basal cell suspension will inject in the dermabrassioned affected areas of Vitiligo, then grafted area will dress up by a tour of silicon covered with a
Treatment - Other
In the first group : Epidermal basal cell suspension will inject in the dermabrassioned affected areas of Vitiligo, then grafted area will dress up by a tour of silicon covered with a layer of woven
In the second group :1 to 3 weeks after basal cell suspensions transplantation when wound healing is comlete, Calcipotriol will be applied topically once a day for 6 months and then the quality of rep

Sponsors

Umbilical Cord Stem Cell Research Center of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with 13 to 60 years old ; The number and size of lesions in at least two areas ; Leukoderma type ; stable vitiligo ; Lack of response to common treatment ; Consent to participate in the study. Exclusion criteria: The patients who have responded well to the treatment ; Patients with cardiovascular disorders ; People aged over 60 years ; Pregnant and lactating women ; Patients under 13 years old ; Patient with history of Koebner phenomenon ; Patient with history of hypertrophic scar tissue and colloid ; The patients with unstable vitiligo.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pigmentation of skin with epidermal basal cell suspension grafting in the treatment of stable vitiligo. Timepoint: Baseline, after recovering of injection site and then monthly for 6 months. Method of measurement: Clinical observation.;Pigmentation of skin with epidermal basal cell suspension grafting and Calcipotriol in the treatment of stable vitiligo. Timepoint: Baseline, after recovering of injection site and then monthly for 6 months. Method of measurement: Clinical observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Anosh

Tabriz University of Medical Sciences

behzadanosh@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026